Enlivex Ltd. cotiza a 0.22 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which…
| Periodo | 2026-09 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $97.80 | $-1.41 | $-1.35 | $-1.20 |
| Estimado | $-0.31 | $-0.45 | $-1.80 | $-2.40 |
| Sorpresa | +31648.4% | -213.3% | +25.0% | +50.0% |
| Métrica | ENLV | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | 63.9% | -40.4% | +104.3% |
| ROA | 53.1% | -32.0% | +85.1% |
| Current Ratio | 193.24 | 2.84 | +190.40 |
| Debt / Equity | — | 0.28 | — |